Skip to evidence report

FIB.adventitial.complement_angiocrine: Studies — page 10

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 5,164 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 9,001–10,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for FIB.adventitial.complement_angiocrine
#Trait / studyIndividual trait IDMean IC score
9001CD27/TNFRSF13B ratioGCST903137772.52e-03
9002DTI autoptx L2 ptr r tractGCST903851862.52e-03
90031,5-anhydroglucitol (1,5-ag) levelsGCST902435292.51e-03
9004Secondary diabetes mellitus (PheCode 249)GCST904756552.51e-03
9005NeurociticismGCST0069402.51e-03
9006Glycoprotein acetyls levelsGCST904973202.50e-03
9007Qualifications - None of the above | EducationUKBB000007292.50e-03
9008FAS levelsGCST904691922.50e-03
9009RP2 levelsGCST904704932.50e-03
9010Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T88ECGU0000882.50e-03
9011Clinical LDL cholesterol levelsGCST904972232.50e-03
9012Free cholesterol in large VLDL (UKB data field 23500)GCST902695972.49e-03
9013DNA methylation GrimAge accelerationGCST900142882.49e-03
9014Phospholipid levels in very large HDLGCST900930122.49e-03
9015PPP1R2/TBL1X ratioGCST903157202.49e-03
9016Concentration of LDL particlesGCST904984182.48e-03
9017Blood cell traits latent factor 7 (white cell)GCST905592492.48e-03
9018LDL cholesterol levelsGCST904983532.47e-03
9019NECTIN2/SPON2 ratioGCST903155302.47e-03
9020DTI TBSS L2 Superior cerebellar peduncle RGCST903844882.46e-03
9021GSN levelsGCST904694092.46e-03
9022EDA2R levelsGCST904690672.46e-03
9023Cholesterol to total lipids ratio in medium HDLGCST900928932.45e-03
9024DYNLT1 levelsGCST904690572.45e-03
9025CANT1/HSPB1 ratioGCST903136172.45e-03
9026ACVRL1 levelsGCST904682112.44e-03
9027Phospholipids in very large HDLGCST905004582.44e-03
9028CD84/CDKN1A ratioGCST903139092.44e-03
9029Concentration of HDL particlesGCST900928262.43e-03
9030Phospholipids to Total Lipids in Large LDL percentageGCST904980582.43e-03
90315alpha-androstan-3beta,17beta-diol monosulfate (2) levelsGCST901998552.43e-03
9032DTI TBSS FA Posterior thalamic radiation LGCST903844092.43e-03
9033ACY1/GSTA1 ratioGCST903131632.43e-03
9034PLA2G4A levelsGCST904702482.43e-03
9035Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T85ECGU0000852.42e-03
9036Glycoprotein acetyls levelsGCST900928212.42e-03
9037MARCO/SIGLEC1 ratioGCST903153872.42e-03
9038Total Lipids in LDLGCST904984052.42e-03
9039Lymphangioleiomyomatosis (sporadic)GCST0083112.42e-03
9040CLIC5 levelsGCST904217402.42e-03
9041Concentration of large VLDL particlesGCST904982262.41e-03
9042MED18/SMAD1 ratioGCST903154132.41e-03
9043CSF1/LTBR ratioGCST903142872.41e-03
9044Volume of left central nucleusGCST904748832.41e-03
9045Diacylglycerol_44:6_[M+H-H2O]1+ levelsGCST900602452.41e-03
9046Sphingomyelin_38:1_[M+H]1+ levelsGCST900603062.41e-03
9047Cholesteryl Esters in Medium HDLGCST904985322.41e-03
9048Abdominal and pelvic pain | Symptoms and signs involving the digestive system and abdomenUKBB000000012.41e-03
9049Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)FING000007682.40e-03
9050CD69/NFATC1 ratioGCST903138792.40e-03
9051ATP5IF1/METAP1D ratioGCST903133912.40e-03
9052ICA1/TANK ratioGCST903151122.40e-03
9053Free cholesterol in medium HDLGCST904985622.40e-03
9054F9/PROC ratioGCST903147482.39e-03
9055T1 CAT volume L IXGCST903841332.39e-03
9056Monounsaturated fatty acids to total fatty acids percentageGCST905023892.38e-03
9057CDH1 levelsGCST904686702.38e-03
9058FYB1 levelsGCST904692842.38e-03
9059BAG6/USP8 ratioGCST903134512.38e-03
9060Sphingomyelin_32:1_[M+H]1+ levelsGCST900602252.37e-03
9061Bread intake | DietUKBB000001052.37e-03
9062SFTPA2 levelsGCST904706132.37e-03
9063mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed)GCST904754522.37e-03
9064Triglycerides to total lipids in large VLDL percentage (UKB data field 23593)GCST902696902.37e-03
9065APOA levelsGCST904680612.37e-03
9066CCS levelsGCST904685942.37e-03
9067Certain disorders involving the immune mechanismFING000002642.37e-03
9068Other non-epithelial cancer of skin | neoplasmsUKBB000006152.37e-03
9069Essential tremor (PheCode 333.1)GCST904758322.36e-03
9070Reticulocyte countGCST900024052.36e-03
9071Acute upper respiratory infections of multiple and unspecified sitesFING000000352.35e-03
9072Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST906685242.34e-03
9073ABHD14B/CCS ratioGCST903131392.34e-03
9074PLA2G7 levelsGCST904702492.33e-03
9075LY6G6C levelsGCST902418302.33e-03
9076High light scatter reticulocyte percentage (UKB data field 30290)GCST904680772.32e-03
9077GUCA2A/LGALS4 ratioGCST903149982.32e-03
9078DTI TBSS L3 Posterior corona radiata LGCST903845512.32e-03
9079AIFM1 levelsGCST904682682.31e-03
9080Body mass indexGCST905029122.31e-03
9081All dysplastic lesions of the cervix uteriFING000000602.31e-03
9082Phospholipids in very small VLDL (UKB data field 23518)GCST902696152.31e-03
9083DAPK2 levelsGCST902408772.31e-03
9084Other malignant neoplasms of skin | Melanoma and other malignant neoplasms of skinUKBB000006132.30e-03
9085GP2/LGALS4 ratioGCST903149602.30e-03
9086Phosphatidylcholine (18:0_20:3) levelsGCST900248762.30e-03
9087PCDH17/SEMA7A ratioGCST903156052.30e-03
9088Maximum digits remembered correctly | Numeric memoryUKBB000004302.27e-03
9089FHIT levelsGCST904692382.26e-03
9090Vitamin B12 deficiency anaemiaFING000014412.26e-03
9091Free cholesterol in chylomicrons and extremely large VLDL (UKB data field 23486)GCST902695832.25e-03
9092Sporadic miscarriageGCST0118882.25e-03
9093Gastric ulcerGCST902709272.24e-03
9094ALDH1A1/CA2 ratioGCST903132432.24e-03
9095Total bile acid levels in pregnancyGCST904541982.23e-03
9096F-seafood liking (derived food-liking factor)GCST900948362.23e-03
9097C5 levelsGCST904685002.23e-03
9098PROK1 levelsGCST904703362.22e-03
9099Non-allergic asthma (mode) (more control exclusions)FING000008692.22e-03
9100Neuroticism score | Mental healthUKBB000004962.22e-03
9101Major depressive disorderGCST0099792.22e-03
9102TGFA levelsGCST904708422.21e-03
9103Sardines likingGCST900948302.21e-03
9104Cancer of bladder (PheCode 189.2)GCST904755982.20e-03
9105APCS levelsGCST904284632.20e-03
9106RAB31 levelsGCST900875522.20e-03
9107Occupation and workplace environment (confirmatory factor analysis Factor 5)GCST903093402.20e-03
9108Tea intake | DietUKBB000008142.19e-03
9109platelet count (mean, inv-norm transformed)GCST904762992.19e-03
9110Metabolic syndromeGCST0096022.19e-03
9111CCN2/SPINT2 ratioGCST903137162.19e-03
9112ARHGAP25/RNF41 ratioGCST903133452.18e-03
9113ADAM23 levelsGCST902409222.18e-03
9114total cholesterol (maximum, inv-norm transformed)GCST904764202.18e-03
9115COL1A1 levelsGCST902407442.18e-03
9116Triglycerides in small HDLGCST904995192.17e-03
9117BCR/DECR1 ratioGCST903134892.17e-03
9118Ground coffee consumptionGCST901329762.16e-03
9119IL27 levelsGCST900120172.16e-03
9120BTN2A1/CSF1 ratioGCST903135412.16e-03
9121FOXO1/NFATC1 ratioGCST903148732.16e-03
9122DiabetesGCST904681242.15e-03
9123Hepatomegaly (PheCode 573.3)GCST904760922.15e-03
9124Benign neoplasm of eye (PheCode 224)GCST904756262.15e-03
9125Celiac disease (PheCode 557.1)GCST900441582.15e-03
9126Triglycerides in medium HDLGCST904986672.15e-03
9127All dysplastic lesions of the cervix uteri, vagina or vulvaFING000000612.15e-03
9128MESD/WWP2 ratioGCST903154262.15e-03
9129RBFOX3 levelsGCST904704322.14e-03
9130potassium (mean, inv-norm transformed)GCST904763072.14e-03
9131PM20D1 levelsGCST904702682.14e-03
9132Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T87ECGU0000872.13e-03
9133Vertiginous syndromes and other disorders of vestibular system (PheCode 386)GCST904759052.13e-03
9134SCGB1A1 levelsGCST904705402.13e-03
9135GM3 ganglioside (d18:1/24:0) levelsGCST900247292.12e-03
9136SLITRK1 levelsGCST904706692.11e-03
9137Non-mucinous epithelial ovarian cancerGCST902441672.11e-03
9138Monounsaturated fatty acids to total fatty acids percentageGCST905023722.11e-03
9139PDCD1/TNFRSF8 ratioGCST903156102.11e-03
9140Dermatitis due to ingested foodFING000004032.10e-03
9141All pneumoniaeFING000000652.10e-03
9142Emotionally unstable personality disorderFING000004952.09e-03
9143Alanine aminotransferase levelsGCST900187232.09e-03
9144CD58/IL10RB ratioGCST903138502.09e-03
9145Cholesteryl Esters in Medium HDLGCST904985382.09e-03
9146Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T488ECGU0004882.09e-03
9147IDP dMRI TBSS OD Superior fronto-occipital fasciculus RGCST900044442.09e-03
9148Hereditary hemolytic anemias (PheCode 282)GCST904757792.09e-03
9149B4GALT1/IFNGR1 ratioGCST903134302.08e-03
9150IDP dMRI TBSS MO Posterior limb of internal capsule LGCST900039712.08e-03
9151FURIN/PLA2G15 ratioGCST903148872.08e-03
9152Non-cancer illness code, self-reported - type 2 diabetes | Medical conditionsUKBB000005222.07e-03
9153Statin-associated type 2 diabetes mellitusGCST906525172.07e-03
9154MMP1/SERPINB6 ratioGCST903154622.07e-03
9155Cancer of prostate (PheCode 185)GCST900418532.06e-03
9156EFNA4/TNFRSF10B ratioGCST903146052.06e-03
9157ENO2/FXYD5 ratioGCST903146592.05e-03
9158Diacylglycerol_42:7_[M+H-H2O]1+ levelsGCST900602262.05e-03
9159Special factor anxiety/tension in mitochondrial haplogroup UGCST902641272.05e-03
9160PCDH17/PTPRM ratioGCST903156032.04e-03
9161CD69/PLXNB3 ratioGCST903138812.04e-03
9162MSRA/SNAP29 ratioGCST903155002.03e-03
9163CFD levelsGCST904687252.03e-03
9164MFGE8 levelsGCST904699002.03e-03
9165PRSS2 levelsGCST902431262.03e-03
9166Omega-3 fatty acids to total fatty acids percentageGCST904991632.02e-03
9167DTI autoptx MD str l tractGCST903852432.02e-03
9168ChronotypeGCST0038372.02e-03
9169Abnormal movement (PheCode 350)GCST904758402.02e-03
9170Benign neoplasm of eye, uveal (PheCode 224.1)GCST904756292.01e-03
9171ZP3 levelsGCST904711052.01e-03
9172Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T482ECGU0004822.01e-03
9173T1 FreeSurfer a2009s rh Pole occipital areaGCST903849312.01e-03
9174SERPINA5 levelsGCST904705852.01e-03
9175GZMB/IL15 ratioGCST903150152.00e-03
9176Free Cholesterol in LDLGCST904983882.00e-03
9177aparc-DKTatlas rh area postcentralGCST900032852.00e-03
9178MED18/TBL1X ratioGCST903154151.99e-03
9179Dementia due to Parkinson's disease (more control exclusions)FING000003921.99e-03
9180B3GNT7 levelsGCST904684111.98e-03
9181Roast chicken likingGCST900948211.97e-03
9182Other/unspecified rheumatoid arthritisFING000011261.97e-03
9183Feeling tenseGCST0069521.96e-03
9184SEMA4D levelsGCST904705731.95e-03
9185Pain in limb (PheCode 773)GCST904762701.95e-03
9186IMMT levelsGCST904696091.94e-03
9187ICA1/MVK ratioGCST903151081.94e-03
9188Colitis, primary sclerosing, strict definitionFING000003131.94e-03
9189Total lipids in large VLDL (UKB data field 23496)GCST902695931.93e-03
9190UCMA levelsGCST902432851.93e-03
9191Cholesterol in small VLDL (UKB data field 23512)GCST902696091.93e-03
9192GSTA1/SULT2A1 ratioGCST903149961.93e-03
9193DTI TBSS MD Anterior corona radiata LGCST903845951.93e-03
9194CRELD2/F2R ratioGCST903142541.93e-03
9195Linoleic acid to total fatty acids percentageGCST905020231.92e-03
9196CCL28/PDGFB ratioGCST903136951.91e-03
9197ESAM/FUT8 ratioGCST903147111.91e-03
9198Ever unenthusiastic/disinterested for a whole week | Mental healthUKBB000002261.91e-03
9199TFF1 levelsGCST904708351.90e-03
9200STX8 levelsGCST904707761.90e-03
9201Moderate-to-vigorous intensity physical activity during leisure timeGCST901043411.90e-03
9202CD69/TIA1 ratioGCST903138881.89e-03
9203X-21285 levelsGCST902005761.89e-03
9204Chronic bronchitis (PheCode 496.2)GCST904760291.89e-03
9205total cholesterol (minimum, inv-norm transformed)GCST904764271.88e-03
9206Dihexosylceramide (d18:1/24:0) levelsGCST900253491.88e-03
9207aseg lh number HolesBeforeFixingGCST900026301.88e-03
9208Triglyceride levelsGCST902786451.88e-03
9209AmygNuclei rh volume Whole-amygdalaGCST900026671.87e-03
9210MZB1/TNFRSF13B ratioGCST903155091.87e-03
9211DFFA/SIRT2 ratioGCST903144621.87e-03
9212SCGN levelsGCST904705441.87e-03
9213Vegetable intake (standard GWA)GCST902673061.86e-03
9214Free cholesterol to total lipids ratio in small HDLGCST900929491.86e-03
9215InsomniaFING000006831.86e-03
9216GALNT7 levelsGCST904692991.86e-03
9217GRAP2/PLPBP ratioGCST903149841.85e-03
9218QPCT levelsGCST904704011.85e-03
9219Cholesteryl esters in small LDL (UKB data field 23548)GCST902696451.84e-03
9220Milk type used: Soy milk vs never have milk (UKB data field 1418)GCST901329431.83e-03
9221High-density lipoprotein levels (MTAG)GCST901791471.83e-03
9222SH2B3/TBL1X ratioGCST903158411.82e-03
9223CD80 on monocyteGCST900020391.82e-03
9224Hair colour (natural, before greying) - Dark brown | Sun exposureUKBB000002971.81e-03
9225Saturated fatty acids to total fatty acids percentageGCST905026971.81e-03
9226Soft cheese likingGCST900948431.81e-03
9227Cholesterol in Large HDLGCST904977091.81e-03
9228KIFBP/TACC3 ratioGCST903152491.81e-03
9229AXIN1/CALCOCO1 ratioGCST903134021.80e-03
9230NECTIN2/TNFRSF1A ratioGCST903155321.80e-03
9231ITGA5 levelsGCST904696351.79e-03
9232HCLS1/TMSB10 ratioGCST903150431.79e-03
9233Free cholesterol to total lipids in medium LDL percentage (UKB data field 23622)GCST902697191.79e-03
9234Biological Father: Cancer, SkinGCST904752401.78e-03
9235IL15/NCR1 ratioGCST903151501.78e-03
9236PODXL2/SEZ6L ratioGCST903157021.78e-03
9237SPON2 levelsGCST904707321.78e-03
9238Bone marrow fat fraction of lumbar vertebra 3GCST906523881.77e-03
9239SNAP29/TJAP1 ratioGCST903158611.77e-03
9240Hepatic cancerGCST900186381.77e-03
9241ADGRE5 levelsGCST904254841.77e-03
9242Blood cell traits latent factor 10 (platelet)GCST905592521.76e-03
9243Disorders of iron metabolism (PheCode 275.1)GCST904757431.76e-03
9244Triglyceride levels in small VLDLGCST901326671.76e-03
9245CD302/CD99 ratioGCST903138051.76e-03
9246SKAP2/VSIR ratioGCST903158491.76e-03
9247Free Cholesterol to Total Lipids in Large VLDL percentageGCST904981991.75e-03
9248NCK2 levelsGCST904700071.75e-03
9249ANPEP/CXADR ratioGCST903132721.75e-03
9250UBA9475 sp002161235 abundance in stoolGCST900326351.75e-03
9251SUOX levelsGCST904707851.74e-03
9252ENG/NOTCH1 ratioGCST903146481.74e-03
9253Total lipids in very small VLDL (UKB data field 23517)GCST902696141.74e-03
9254Phospholipids in very small VLDLGCST905008511.74e-03
9255DTI autoptx MD ifo r tractGCST903852331.74e-03
9256FCRL1/TNFRSF13C ratioGCST903147961.74e-03
9257Free Cholesterol in VLDLGCST905002171.73e-03
9258RNASET2 levelsGCST904704811.73e-03
9259Body mass index (BMI, maximum, inv-normal transformed)GCST904751531.73e-03
9260Total testosterone levelsGCST900121141.73e-03
9261RNF43 levelsGCST904704861.73e-03
9262Total lipid levels in medium HDLGCST900928981.73e-03
9263Reaction time (standard GWA)GCST902672961.73e-03
9264X-11787 levelsGCST902004651.73e-03
9265HPSE levelsGCST904694731.72e-03
9266HealthspanGCST0074061.72e-03
9267GPI levelsGCST902412691.71e-03
9268DLL1/NBL1 ratioGCST903144961.71e-03
9269SEZ6L levelsGCST904706071.71e-03
9270Cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23581)GCST902696781.70e-03
9271BAX levelsGCST904684241.70e-03
9272Extrapyramidal and movement disordersFING000005271.69e-03
9273EDAR/SDC4 ratioGCST903145851.69e-03
9274CLU levelsGCST904687931.68e-03
9275Cholesterol in Medium HDLGCST904984921.68e-03
9276Takes medication for circulatory problem?GCST904752181.68e-03
9277N-acetyl-1-methylhistidine levelsGCST902006901.68e-03
9278SNX2 levelsGCST904707011.67e-03
9279DorsalgiaFING000004721.67e-03
9280CLEC1B levelsGCST904687681.67e-03
9281AHSP/CA2 ratioGCST903132151.67e-03
9282CD84/GP6 ratioGCST903139141.67e-03
9283CLEC1B/ITGB5 ratioGCST903140941.66e-03
9284ERBIN/LYN ratioGCST903146941.66e-03
9285Phospholipids to Total Lipids in IDL percentageGCST904976441.66e-03
9286Annual healthcare costGCST902926041.66e-03
9287CPXM1/HBEGF ratioGCST903142191.66e-03
9288VWC2L levelsGCST904710631.65e-03
9289Mean corpuscular haemoglobin concentration | Blood countUKBB000004481.65e-03
9290ENO1 levelsGCST904691091.65e-03
9291Worry too long after an embarrassing experienceGCST0069461.65e-03
9292FCGR2A/FCGR2B ratioGCST903147931.64e-03
9293Cholesteryl ester levels in LDLGCST900928841.64e-03
9294HAVCR2 levelsGCST904694321.64e-03
9295FUT8/SPARC ratioGCST903148931.64e-03
9296Orange juice likingGCST900948061.64e-03
9297Cholesteryl Esters in LDLGCST904983631.64e-03
9298STK11/USP8 ratioGCST903158921.63e-03
9299Polyunsaturated fatty acids to saturated fatty acids ratioGCST905021681.63e-03
9300IL16 levelsGCST904695571.63e-03
9301Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ levelsGCST900602841.62e-03
9302C8B levelsGCST904685031.62e-03
9303CCL18 levelsGCST904685701.61e-03
9304Phospholipids to total lipids ratio in IDLGCST900928401.61e-03
9305Triglycerides to Total Lipids in Large VLDL percentageGCST904982871.61e-03
9306Estradiol levelsGCST900121051.61e-03
9307Epstein-Barr virus ZEBRA antibody levelsGCST900069011.60e-03
93085-hydroxyindole sulfate levelsGCST902000501.60e-03
9309Free thyroxine levels within normal range in pregnancyGCST904351961.60e-03
93105,6-dihydrouridine levelsGCST901997671.60e-03
9311Docosahexaenoic acid levelsGCST905022431.60e-03
9312Ulcerative colitis (strict definition, require KELA, min 2 HDR)FING000013881.60e-03
9313PAG1 levelsGCST904701471.59e-03
9314SERPINE2 levelsGCST904705971.59e-03
9315TREML1 levelsGCST904709611.59e-03
9316Monounsaturated fatty acids to total fatty acids percentageGCST905020511.59e-03
9317Free Cholesterol to Total Lipids in Medium LDL percentageGCST904987841.59e-03
9318CFP levelsGCST904687311.59e-03
9319Parental longevity (both parents in top 10%)GCST0066981.59e-03
9320Obstructive chronic bronchitis (PheCode 496.21)GCST904760301.58e-03
9321Diabetes mellitus (UKB data field 2443)GCST900436271.58e-03
9322Thyrotoxicosis with or without goiter (PheCode 242)GCST904756431.58e-03
9323KIR3DL1 levelsGCST904696871.58e-03
9324Cholesterol to Total Lipids in Very Large VLDL percentageGCST905005391.58e-03
9325IDP dMRI ProbtrackX ICVF mcpGCST900043911.57e-03
9326GRAP2/TYMP ratioGCST903149901.57e-03
9327TACC3/TRIAP1 ratioGCST903159011.57e-03
9328Triacylglycerol_56:7_[M+NH4]1+ levelsGCST900605511.56e-03
9329Sum neutrophil eosinophil countsGCST0046131.56e-03
9330Total lipids in small LDLGCST904996561.56e-03
9331PGLYRP2 levelsGCST904702201.55e-03
9332SIGLEC8 levelsGCST900898861.55e-03
9333PROC levelsGCST904703351.55e-03
9334WFDC5 levelsGCST900895981.55e-03
9335Polyunsaturated fatty acids to total fatty acids percentageGCST905026441.54e-03
9336Cholesterol to Total Lipids in Very Large VLDL percentageGCST905005421.54e-03
9337CD55/CHI3L1 ratioGCST903138451.54e-03
9338T1 FIRST volume R PutaGCST903839951.54e-03
9339Blood cell traits latent factor 23 (white cell)GCST905592651.54e-03
9340Trauma exposureGCST0099821.54e-03
9341Chicken likingGCST900947321.53e-03
9342PRCP/SELE ratioGCST903157261.53e-03
9343NPC2 levelsGCST904700681.53e-03
9344Attention deficit hyperactivity disorder (adjusted for age, sex)GCST902751471.53e-03
9345DNMBP/TJAP1 ratioGCST903145211.53e-03
9346Immature reticulocyte fraction | Blood countUKBB000003551.53e-03
9347Chronic dermatitis due to solar radiation (PheCode 938.2)GCST904762881.52e-03
9348PDZK1 levelsGCST904702031.52e-03
9349Honey likingGCST900947821.52e-03
9350TNFRSF4 levelsGCST904709131.52e-03
9351Docosahexaenoic acid to total fatty acids percentageGCST905019971.52e-03
9352Free cholesterol in large VLDLGCST904981811.52e-03
9353Body mass index (MTAG)GCST901791501.52e-03
9354EZR levelsGCST904691621.52e-03
9355CD244 levelsGCST902747711.51e-03
9356DOK2/PPP1R2 ratioGCST903145371.51e-03
9357BMI and adiposity (confirmatory factor analysis Factor 7)GCST903093421.51e-03
9358CCL5/TACC3 ratioGCST903137071.51e-03
9359Myeloid white cell countGCST0046261.51e-03
9360DNAJB1/EIF4B ratioGCST903145081.51e-03
9361MYH9 levelsGCST904699751.50e-03
9362Linoleic acid levelsGCST905020091.50e-03
9363Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905023991.50e-03
9364Total lipids in large VLDLGCST904982071.50e-03
9365Nonalcoholic steatohepatitisFING000008791.49e-03
9366APOA1 levelsGCST904971221.49e-03
9367Long-standing illness, disability or infirmity | General healthUKBB000004091.49e-03
9368IDP dMRI TBSS FA Cingulum cingulate gyrus RGCST900039111.49e-03
9369CXCL5/EDAR ratioGCST903143491.48e-03
9370DTI TBSS FA Posterior thalamic radiation RGCST903844081.48e-03
9371Granulocyte countGCST0046141.48e-03
9372Phospholipids in very small VLDLGCST905008401.48e-03
9373Mean corpuscular hemoglobin varianceGCST905656931.47e-03
9374Diseases of white blood cells (PheCode 288)GCST904758121.47e-03
9375Glycine levelsGCST904973161.47e-03
9376Ever SmokerFING000005221.47e-03
9377rfMRI connectivity (ICA100 edge 605)GCST900054581.47e-03
9378CD84/DAG1 ratioGCST903139101.46e-03
9379Plasma 11beta-hydroxyandrosterone glucuronide levels in chronic kidney diseaseGCST902643211.45e-03
9380Platelet count (UKB data field 30080)GCST904680951.45e-03
9381DTI autoptx L3 ilf r tractGCST903852081.45e-03
9382IPCEF1/SPARC ratioGCST903151861.45e-03
9383IDP dMRI ProbtrackX OD slf lGCST900044711.45e-03
9384CXCL1 levelsGCST900120191.45e-03
9385CD69/SNAP29 ratioGCST903138871.45e-03
9386Cholesteryl esters to total lipids in medium LDL percentage (UKB data field 23621)GCST902697181.45e-03
9387CD99L2 levelsGCST904686571.44e-03
9388Free Cholesterol to Total Lipids in Medium VLDL percentageGCST904989761.44e-03
9389Triglyceride levels (UKB data field 30870)GCST904681061.44e-03
9390Total Lipids in HDLGCST904974011.43e-03
9391Testosterone | Blood biochemistryUKBB000008161.43e-03
9392Physical activity (Principal component 2)GCST900614231.43e-03
9393Diacylglycerol_32:2_[M+H-H2O]1+ levelsGCST900601681.43e-03
9394CPXM1/SPARC ratioGCST903142221.43e-03
9395EPHB4 levelsGCST904691321.43e-03
9396ZNRD2 levelsGCST904711031.42e-03
9397platelet count (maximum, inv-norm transformed)GCST904762961.42e-03
9398DCXR/KYNU ratioGCST903144381.42e-03
9399Reaction time (baseline)GCST905658381.42e-03
9400Non-cancer illness code, self-reported - diabetes | Medical conditionsUKBB000005081.41e-03
9401BTN2A1 levelsGCST904684801.41e-03
9402FXN/METAP1D ratioGCST903148971.41e-03
9403KLK8 levelsGCST904254921.41e-03
9404QC rfMRI cleaned inverse tSNRGCST900063581.41e-03
9405T1 CAT volume L PlanumPolareGCST903840861.40e-03
9406Treatment or medication use - metformin (UKB data field 20003_1140884600)GCST900422451.40e-03
9407Obesity related asthmaFING000008971.39e-03
9408CD36 levelsGCST904686271.39e-03
9409Monocyte countGCST900187471.39e-03
9410FAS levelsGCST904277021.39e-03
9411CEACAM5 levelsGCST904686961.38e-03
9412CHMP1A/EREG ratioGCST903140481.38e-03
9413Tyrosine levelsGCST905001431.38e-03
9414Sum basophil neutrophil countsGCST0046201.38e-03
9415Cholesteryl Esters in IDLGCST904975251.38e-03
9416CDCP1/IL18BP ratioGCST903139371.38e-03
9417CGREF1 levelsGCST904687351.38e-03
9418Feeling fed-upGCST0069471.38e-03
9419AAGAB levelsGCST906174731.38e-03
9420PRTN3/RETN ratioGCST903157341.38e-03
9421Saturated fatty acids to total fatty acids percentageGCST905027001.37e-03
9422Rheumatoid arthritisGCST901322231.37e-03
9423Time spent driving | Physical activityUKBB000008181.37e-03
9424LDL cholesterolGCST0007591.37e-03
9425GSTA1/RBP5 ratioGCST903149951.37e-03
9426ANPEP/NT5E ratioGCST903132741.36e-03
9427Total concentration of lipoprotein particles (UKB data field 23427)GCST902695241.36e-03
9428Number of sexual partners in opposite-sex sexual behaviorGCST900264801.36e-03
9429Volume of left medial nucleusGCST904749761.36e-03
9430HBEGF/LAT2 ratioGCST903150321.36e-03
9431Phospholipids to total lipids in very large HDL percentage (UKB data field 23629)GCST902697261.34e-03
9432DTI TBSS L3 Posterior thalamic radiation RGCST903845521.34e-03
9433PPP1R2/TACC3 ratioGCST903157191.34e-03
9434Triglycerides in large VLDLGCST904982671.34e-03
9435Hemoglobin concentration varianceGCST905656851.34e-03
9436ITGA6 levelsGCST904696361.34e-03
9437Cholesterol esters in very large HDLGCST905003541.34e-03
9438DTI TBSS L3 External capsule LGCST903845571.33e-03
9439Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905024101.33e-03
9440Concentration of very small VLDL particles (UKB data field 23516)GCST902696131.33e-03
9441Recurrent or chronic depressionFING000012431.33e-03
9442Recent feelings of tiredness or low energy | DepressionUKBB000007401.33e-03
9443Nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [LDH] (PheCode 573.6)GCST904760941.33e-03
9444MST1 levelsGCST904699521.32e-03
9445VAMP5 levelsGCST904710241.32e-03
9446Illnesses of father - Diabetes | Family historyUKBB000003411.32e-03
9447Pregnanediol-3-glucuronide levelsGCST901999171.32e-03
9448Glycine levelsGCST902007071.32e-03
9449Reticulocyte countGCST900259721.32e-03
9450Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)FING000007661.31e-03
9451Mean time to correctly identify matches | Reaction timeUKBB000004531.31e-03
9452Cholesterol to Total Lipids in Large VLDL percentageGCST904981251.31e-03
9453CLEC5A levelsGCST904687761.30e-03
9454platelet count (minimum, inv-norm transformed)GCST904763021.30e-03
9455CLEC4G/MERTK ratioGCST903141211.30e-03
9456CASP3/SERPINE1 ratioGCST903136431.30e-03
9457Remnant cholesterol (non-HDL, non-LDL -cholesterol)GCST904993351.30e-03
9458Lager likingGCST900947891.29e-03
9459Triglycerides in IDLGCST904976711.29e-03
9460CCL25/PRSS27 ratioGCST903136941.29e-03
9461Been in a confiding relationship as an adult | Traumatic eventsUKBB000000881.29e-03
9462INSR levelsGCST904696231.29e-03
9463Gallstone diseaseGCST901285181.29e-03
9464ENO3 levelsGCST904691111.28e-03
9465HippSubfield rh volume CA4-headGCST900027041.28e-03
9466CCN2/SERPINB1 ratioGCST903137151.28e-03
9467Red blood cell countGCST900024031.28e-03
9468NOMO1 levelsGCST904700601.27e-03
9469PDGFA/USP8 ratioGCST903156211.27e-03
9470DAG1/DBNL ratioGCST903143721.27e-03
9471F-sweet food liking (derived food-liking factor)GCST900948541.27e-03
9472CDH1/CST3 ratioGCST903139461.27e-03
9473Neutrophil percentage of white cells varianceGCST905657011.27e-03
9474CEACAM8 levelsGCST904686981.26e-03
9475MINPP1 levelsGCST902419781.26e-03
9476Omega-6 fatty acids to total fatty acids percentageGCST905021271.26e-03
9477Ximenoylcarnitine (C26:1) levelsGCST902001491.26e-03
9478Concentration of very large HDL particlesGCST905004361.26e-03
9479Phosphatidylglycerol (34:1) levelsGCST900250611.26e-03
9480Substance abuse (more control exclusions)FING000013411.26e-03
9481High density lipoprotein cholesterol levelsGCST902786351.26e-03
9482TREM2 levelsGCST904709601.25e-03
9483DRG2/SEMA4D ratioGCST903145541.25e-03
9484LDLR/PCSK9 ratioGCST903153111.25e-03
9485ST3GAL1 levelsGCST904707521.25e-03
9486Phospholipids to total lipids in medium VLDL percentage (UKB data field 23594)GCST902696911.25e-03
9487Cholesterol to Total Lipids in Large LDL percentageGCST904979291.25e-03
9488LAT2 levelsGCST904697391.24e-03
9489Reticulocyte count (UKB data field 30250)GCST904681001.24e-03
9490LZTFL1 levelsGCST904698341.24e-03
9491Stearoylcarnitine (C18) levelsGCST901997431.24e-03
9492Total cholesterol minus HDL-C levelsGCST904991301.24e-03
9493NRAC levelsGCST906179911.24e-03
9494RWDD1/SUMF2 ratioGCST903157951.23e-03
9495Non-cancer illness year/age first occurred | Medical conditionsUKBB000005231.23e-03
9496LBR/MAD1L1 ratioGCST903152951.23e-03
9497Neutrophil countGCST0046291.23e-03
9498Neutrophill percentage | Blood countUKBB000004981.22e-03
9499Free cholesterol in very large VLDLGCST905005751.22e-03
9500SUGT1/TBL1X ratioGCST903158971.22e-03
9501Total cholines levels (UKB data field 23436)GCST902695331.22e-03
9502Cognitive processing speedGCST904461681.22e-03
9503F-coffee/alcohol liking (derived food-liking factor)GCST900947371.22e-03
9504ErysipelasFING000005181.22e-03
9505Phosphatidylcholine acyl-alkyl C36:5 levelsGCST902400731.21e-03
9506CASP3/LYN ratioGCST903136351.21e-03
9507Total free cholesterol levels (UKB data field 23419)GCST902695161.20e-03
9508SERPINE1 levelsGCST904705961.20e-03
9509Infective dermatitisFING000006731.20e-03
9510NeuroticismGCST0037701.20e-03
9511CD79B/TNFRSF4 ratioGCST903139031.19e-03
9512Epiandrosterone sulfate levelsGCST901997521.19e-03
9513Salad / raw vegetable intake | DietUKBB000007611.19e-03
9514FADD/LACTB2 ratioGCST903147671.18e-03
9515Primary sclerosing cholangitisGCST0040301.18e-03
9516HBEGF/WWP2 ratioGCST903150381.18e-03
9517EREG/TIMP3 ratioGCST903147081.18e-03
9518CTSC/PLA2G15 ratioGCST903143111.18e-03
9519Common executive functionGCST901625471.17e-03
9520Saturated fatty acids to total fatty acids percentageGCST905026851.17e-03
9521Free Cholesterol to Total Lipids in IDL percentageGCST904975761.17e-03
9522Linoleic acid levelsGCST905023111.17e-03
9523Cholesterol to Total Lipids in Small LDL percentageGCST904995641.17e-03
9524ATOX1 levelsGCST904683851.17e-03
9525IMPA1 levelsGCST904696101.17e-03
9526Chest pain or discomfort | Chest painUKBB000001281.17e-03
9527Familial combined hyperlipidemia defined by Brunzell criteriaGCST901040031.17e-03
9528CLPS/PRSS2 ratioGCST903141411.16e-03
9529Hidradenitis suppurativaFING000006211.16e-03
9530Free cholesterol levels in chylomicrons and extremely large VLDLGCST905009651.16e-03
9531Free cholesterol in very small VLDLGCST905007741.16e-03
9532BCAM/PCDH17 ratioGCST903134751.16e-03
9533LDL cholesterol levelsGCST900928831.15e-03
9534Shellfish likingGCST900948381.15e-03
9535Triglycerides to total lipids in small HDL percentage (UKB data field 23648)GCST902697451.15e-03
9536Globe artichoke likingGCST900947711.15e-03
9537Lymphoid leukaemia (controls excluding all cancers)FING000007411.15e-03
9538wg rh intensity-contrast insulaGCST900038611.15e-03
9539CST6/FABP9 ratioGCST903143011.15e-03
9540Omega-6 fatty acids to total fatty acids percentageGCST905025411.15e-03
9541Total Dihexosylceramide levelsGCST900251931.14e-03
9542ACVRL1/TNFRSF9 ratioGCST903131601.14e-03
9543ATG4A/NSFL1C ratioGCST903133681.14e-03
9544SMPD3 levelsGCST904706851.14e-03
9545Smoking status (weighted GWA)GCST902673031.14e-03
9546PHOSPHO1 levelsGCST904702271.14e-03
9547Triglycerides to Total Lipids in Medium HDL percentageGCST904986891.13e-03
9548FAM151A levelsGCST902424501.13e-03
9549NMNAT1 levelsGCST904700571.13e-03
9550Free cholesterol in very large HDLGCST905003801.13e-03
9551KRT19 levelsGCST904697171.13e-03
9552ALB levelsGCST902695761.13e-03
9553Total lipids in small LDL (UKB data field 23545)GCST902696421.13e-03
9554Fruit juice likingGCST900947681.13e-03
9555KLK6 levelsGCST904697051.13e-03
9556IL1R1 levelsGCST904255631.13e-03
9557NeuroticismGCST0052321.13e-03
9558Triglycerides in VLDL (UKB data field 23408)GCST902695051.12e-03
9559wg lh intensity-contrast rostralanteriorcingulateGCST900038171.12e-03
9560HippSubfield lh volume Whole-hippocampal-headGCST900026881.12e-03
9561RSPO1/SFRP1 ratioGCST903157911.12e-03
9562Phospholipids in HDLGCST904974371.12e-03
9563Fruit intake (weighted GWA)GCST902672831.12e-03
9564Cholesteryl ester levels in large LDLGCST900928581.12e-03
95651-palmitoylglycerophosphoethanolamine levelsGCST902438351.11e-03
9566Sphingomyelin_34:1_[M+H]1+ levelsGCST900602391.11e-03
9567CXCL11/VTA1 ratioGCST903143371.11e-03
9568CD244/FCRL6 ratioGCST903137651.11e-03
9569Triacylglycerol_58:7_[M+NH4]1+ levelsGCST900605641.11e-03
9570Total lipid levels in IDLGCST901326331.11e-03
9571Cancer within the respiratory system (PheCode 165)GCST904755711.10e-03
9572Glycated hemoglobin levelsGCST900022441.10e-03
9573Phospholipids in medium VLDL (UKB data field 23504)GCST902696011.10e-03
9574Cholesteryl esters to total lipids in very large VLDL percentage (UKB data field 23586)GCST902696831.10e-03
9575Juvenile rheumatoid arthirtisFING000007061.10e-03
9576Red blood cell countGCST902786411.10e-03
9577Ratio of polyunsaturated fatty acids to monounsaturated fatty acidsGCST900929401.10e-03
9578Feeling miserableGCST0069431.09e-03
9579Phospholipids to Total Lipids in Medium VLDL percentageGCST904990441.09e-03
9580CDKN1A/YES1 ratioGCST903139801.09e-03
9581Average diameter for LDL particles (UKB data field 23432)GCST902695291.09e-03
9582Metabolic syndromeGCST904444891.09e-03
9583ANXA3/ENO2 ratioGCST903132811.08e-03
9584CD300C/GOLM2 ratioGCST903137881.08e-03
9585Lichen sclerosus et atrophicusFING000007231.08e-03
9586ICD10 O13: Gestational hypertensionGCST904542321.08e-03
9587ROBO1 levelsGCST904704891.08e-03
9588CXADR/MME ratioGCST903143291.08e-03
9589DTI autoptx MD fmi tractGCST903852311.08e-03
9590DNAJB1/STIP1 ratioGCST903145131.08e-03
9591LCN2/S100A12 ratioGCST903153091.08e-03
9592SCLY levelsGCST904705461.07e-03
9593Disorders of orbitFING000004491.07e-03
9594Mean corpuscular hemoglobin concentrationGCST0046051.07e-03
9595Saturated fatty acids levelsGCST905026711.07e-03
9596Raw carrot likingGCST900948181.07e-03
9597Concentration of very large HDL particlesGCST900930111.06e-03
9598Ratio of monounsaturated fatty acids to total fatty acidsGCST900929291.06e-03
9599Free Cholesterol to Total Lipids in Medium HDL percentageGCST904985831.06e-03
9600TIMP1 levelsGCST904708691.06e-03
9601wg rh intensity-contrast medialorbitofrontalGCST900038401.06e-03
9602SERPING1 levelsGCST904706001.05e-03
9603CA5A levelsGCST904685141.05e-03
9604ANGPT1 levelsGCST904683001.05e-03
9605HEXIM1/TRIAP1 ratioGCST903150541.05e-03
9606Facial wrinkles (under eye)GCST900949031.04e-03
9607Degree of unsaturationGCST905027481.04e-03
9608APP/TMSB10 ratioGCST903133321.04e-03
9609Type 2 diabetesGCST900860721.04e-03
9610CRKL/MANF ratioGCST903142691.04e-03
9611Concentration of medium VLDL particles (UKB data field 23502)GCST902695991.03e-03
9612aparc-a2009s lh area S-centralGCST900033411.03e-03
9613Gamma glutamyl transpeptidaseGCST900187341.03e-03
9614X-03056--N-[3- 2-Oxopyrrolidin-1-yl propyl]acetamide levelsGCST902436191.03e-03
9615Reaction timeGCST0062681.03e-03
9616CTSD levelsGCST904689101.03e-03
9617DTI TBSS L2 Tapetum LGCST903845231.02e-03
9618DTI TBSS MD External capsule LGCST903846051.02e-03
9619Back pain (PheCode 760)GCST904762661.02e-03
9620DTI TBSS L2 Genu of corpus callosumGCST903844781.02e-03
9621DPEP1 levelsGCST904690301.02e-03
9622Polymyalgia rheumaticaFING000011881.02e-03
9623Cholesteryl esters in large VLDL (UKB data field 23499)GCST902695961.02e-03
9624LY6D/WFDC12 ratioGCST903153461.02e-03
9625DLL1/NECTIN4 ratioGCST903144971.02e-03
9626TRIM21 levelsGCST904709641.02e-03
9627REG1A/REG4 ratioGCST903157621.01e-03
9628Prostate cancerGCST900118081.01e-03
9629Total cholesterol levelsGCST905000221.00e-03
9630Lignoceroylcarnitine (C24) levelsGCST902001371.00e-03
9631MAD1L1/POLR2F ratioGCST903153549.98e-04
9632Nonalcoholic fatty liver diseaseFING000008789.90e-04
9633Spread type - Other type of spread/margarine | DietUKBB000007959.89e-04
9634Total lipid levels in large LDLGCST900928629.89e-04
9635Bone marrow fat fraction of thoracic vertebra 10GCST906523829.87e-04
9636N-acetylphenylalanine levelsGCST902006779.87e-04
9637Medication use (drugs used in diabetes)GCST900187619.86e-04
9638Number of fluid intelligence questions attempted within time limit | Fluid intelligence / reasoningUKBB000005379.80e-04
9639Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585)GCST902696829.77e-04
9640CD83/HAVCR2 ratioGCST903139049.77e-04
9641wg lh intensity-contrast cuneusGCST900037969.76e-04
9642VLDL cholesterol levels (UKB data field 23403)GCST902695009.76e-04
9643Phospholipids to Total Lipids in Medium HDL percentageGCST904986519.75e-04
9644Mucosal proctocolitisFING000008419.75e-04
9645EBAG9/MITD1 ratioGCST903145669.74e-04
9646Birth weight known - No | Early life factorsUKBB000000969.71e-04
9647Cooked vegetables consumptionGCST901329779.68e-04
9648Monounsaturated fatty acid levelsGCST905023599.65e-04
9649Number of days/week of moderate physical activity 10+ minutes | Physical activityUKBB000005339.65e-04
9650THY1/TNFRSF21 ratioGCST903159199.64e-04
9651Cholesterol levels in small LDLGCST900929569.62e-04
9652IGFBP3 levelsGCST901026249.58e-04
9653CFH levelsGCST904687299.58e-04
9654Cholesterol to Total Lipids in Large VLDL percentageGCST904981309.57e-04
9655PLXNB3/SNAP23 ratioGCST903156939.57e-04
9656Triglycerides in medium HDLGCST904986729.57e-04
9657STMN3 levelsGCST902428949.56e-04
9658Phosphatidylcholines levels (UKB data field 23437)GCST902695349.55e-04
9659Triglycerides to Total Lipids in Small HDL percentageGCST904995439.54e-04
9660Total lipid levels in LDLGCST900928869.52e-04
9661HDL x anxiety interaction (2df test)GCST905706659.51e-04
9662PSAPL1 levelsGCST904703509.50e-04
9663PTPN6 levelsGCST904703779.49e-04
9664PDGFA/PLA2G4A ratioGCST903156159.49e-04
9665Biological Father: High cholesterolGCST904752429.48e-04
9666ADIPOQ levelsGCST902930869.47e-04
9667CASP3/MESD ratioGCST903136369.45e-04
9668TPSAB1 levelsGCST904709519.43e-04
9669Cholesterol levels in medium LDLGCST900929049.43e-04
9670All influenzaFING000000649.39e-04
9671Degree of unsaturationGCST905022319.37e-04
9672Frailty (Factor 1 - Limited Social Support)GCST906240479.37e-04
9673REG1B levelsGCST904704489.37e-04
9674Cholesteryl Esters to Total Lipids in IDL percentageGCST904975399.34e-04
9675Total triglycerides levelsGCST905001409.32e-04
9676IDP dMRI ProbtrackX ICVF ml rGCST900043939.31e-04
96771-methylhistidine levelsGCST901996919.31e-04
9678CD200/CLEC4G ratioGCST903137469.31e-04
9679Platelet count | Blood countUKBB000006469.30e-04
9680Principal component-derived dietary pattern 8GCST901330139.29e-04
9681IDP T1 FAST ROIs V cerebellum VIIbGCST900025769.27e-04
9682HMOX1 levelsGCST904694659.27e-04
9683Left-hemisphere salience/ventral attention network to hippocampus white-matter structural connectivityGCST903027239.25e-04
9684Inflammatory bowel diseaseGCST904321829.24e-04
9685Fed-up feelings | Mental healthUKBB000002429.23e-04
9686DTI TBSS L3 Superior cerebellar peduncle RGCST903845369.23e-04
9687Type 1 diabetes, definitions combinedFING000013809.22e-04
9688Usual side of head for mobile phone use - Right | Electronic device useUKBB000008909.21e-04
9689Total lipids in large LDLGCST904980219.19e-04
9690DTI autoptx FA ifo r tractGCST903851259.19e-04
9691Cholesterol levels in chylomicrons and extremely large VLDLGCST905009059.13e-04
9692Spread type: Butter and margarine spreads vs oil-based spreads (UKB data field 1428)GCST901329519.12e-04
9693UMOD levelsGCST904710099.11e-04
9694TGFBI/VASN ratioGCST903159159.09e-04
9695SELP levelsGCST904705699.09e-04
9696Other reaction to severe stress, and adjustment disordersFING000010929.08e-04
9697Total esterified cholesterol levelsGCST905000349.08e-04
9698Cholesteryl esters in VLDL (UKB data field 23416)GCST902695139.06e-04
9699YTHDF3 levelsGCST904710919.06e-04
9700PTPRF/SDC1 ratioGCST903157529.05e-04
9701Insomnia (standard GWA)GCST902672869.04e-04
9702Mouth/teeth dental problems - Bleeding gums | MouthUKBB000004859.03e-04
9703ICD10 C61: Malignant neoplasm of prostateGCST900438949.03e-04
9704TNFRSF13C levelsGCST904709069.02e-04
9705PFKFB2/SRP14 ratioGCST903156508.99e-04
9706Other systemic involvement of connective tissue (FG)FING000011168.99e-04
9707Time spent outdoors in winter | Sun exposureUKBB000008198.99e-04
9708Multiple sclerosisGCST904758338.95e-04
9709Cholesterol levels in very large HDLGCST905003108.95e-04
9710TNFRSF1A/TNFRSF1B ratioGCST903159378.94e-04
9711Total cholesterol levels (UKB data field 23400)GCST902694978.92e-04
9712BGN levelsGCST904684418.88e-04
9713Migraine with auraFING000008198.86e-04
9714Treatment/medication code - allopurinol | MedicationsUKBB000008398.86e-04
9715Concentration of medium VLDL particlesGCST904990178.80e-04
9716F-acquired taste liking (derived food-liking factor)GCST900947918.80e-04
9717ENO2/PRSS27 ratioGCST903146668.80e-04
9718Actinic keratosisFING000000138.79e-04
9719KDM3A levelsGCST904696718.79e-04
9720Treatment speciality of consultant (recoded) - General medicine | Summary AdministrationUKBB000008328.76e-04
9721F-fish liking (derived food-liking factor)GCST900947628.76e-04
9722ITGB1BP2/WASF1 ratioGCST903152248.73e-04
9723Other localized connective tissue disordersFING000010668.71e-04
9724Liver volumeGCST900166668.71e-04
9725PLG levelsGCST904702578.70e-04
9726Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST905009438.69e-04
9727Suggestive for eosinophilic asthmaFING000013448.68e-04
9728Sphingomyelins levelsGCST904999728.68e-04
9729Current employment status - Unable to work because of sickness or disability | EmploymentUKBB000001608.64e-04
9730RILP/RWDD1 ratioGCST903157788.63e-04
9731KIRREL2/PLA2G1B ratioGCST903152518.60e-04
9732Do you smoke now?GCST904763898.59e-04
9733Other obstetric traumaFING000010828.57e-04
9734Cognition and processing speed (confirmatory factor analysis Factor 34)GCST903093688.57e-04
9735CCL3 levelsGCST900120558.56e-04
9736Concentration of VLDL particles (UKB data field 23428)GCST902695258.56e-04
9737Polyunsaturated fatty acid levelsGCST905026238.56e-04
9738LGALS9/SIGLEC1 ratioGCST903153238.56e-04
9739Treatment/medication code - simvastatin | MedicationsUKBB000008598.52e-04
9740Worry too long after embarrassment | Mental healthUKBB000009228.52e-04
9741Age hay fever, rhinitis or eczema diagnosed | Medical conditionsUKBB000000158.49e-04
9742APOA1 levelsGCST904971198.45e-04
9743PAPPA levelsGCST904701578.45e-04
9744LAT/SPARC ratioGCST903152888.44e-04
9745Total lipids in IDLGCST904976018.41e-04
9746DBI/MESD ratioGCST903144098.40e-04
9747Monounsaturated fatty acids to total fatty acids percentageGCST904991098.40e-04
9748Triglycerides in very small VLDLGCST905008738.39e-04
9749Types of physical activity in last 4 weeks - Light DIY (eg: pruning, watering the lawn) | Physical activityUKBB000008718.39e-04
9750ICAM3/TNFRSF13B ratioGCST903151248.39e-04
9751CCN2/TPP1 ratioGCST903137188.38e-04
9752RadiculopathyFING000012388.36e-04
9753ADH4 levelsGCST904682448.35e-04
9754RHOC levelsGCST904704678.35e-04
9755Mental and behavioural disorders due to use of other stimulants, including caffeineFING000008118.35e-04
9756Lysophosphatidylcholine (26:0) [sn2] levelsGCST900241898.34e-04
9757Histidine levelsGCST904974798.33e-04
9758CA5A/GSTA1 ratioGCST903135918.33e-04
9759CD101 levelsGCST904685968.31e-04
9760GLOD4/MIF ratioGCST903149398.28e-04
9761Cholesteryl Esters in Large HDLGCST904977518.27e-04
9762Triglycerides in medium LDLGCST904988648.22e-04
9763Venous thromboembolismFING000014278.20e-04
9764Coffee intake | DietUKBB000001388.20e-04
9765CCL2/CCL7 ratioGCST903136968.19e-04
9766Alcohol dependenceFING000000508.19e-04
9767ATP5IF1/F2R ratioGCST903133848.18e-04
9768Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T81ECGU0000818.18e-04
97693,4-dihydroxybutyrate levelsGCST901998168.17e-04
9770CLEC1B/PPP1R2 ratioGCST903141018.15e-04
9771CLEC1B/LBR ratioGCST903140958.15e-04
9772TNFAIP8 levelsGCST904708988.14e-04
9773Concentration of very large HDL particlesGCST905004318.13e-04
9774Nervous feelings | Mental healthUKBB000004958.11e-04
9775Phospholipids in HDLGCST904974308.11e-04
9776ATP5IF1/FIS1 ratioGCST903133858.09e-04
9777Phospholipids in medium VLDLGCST904990258.08e-04
9778Methods of admission to hospital (recoded) - Elective admission: Booked | Summary AdministrationUKBB000004618.07e-04
9779FOLH1 levelsGCST904256618.06e-04
9780Total phospholipids in lipoprotein particles (UKB data field 23411)GCST902695088.04e-04
9781CD27/TGFBR2 ratioGCST903137768.04e-04
9782ASGR2 levelsGCST904683768.01e-04
9783X-24328 levelsGCST902006247.99e-04
9784IL1RL2 levelsGCST904695757.98e-04
9785AXIN1/CDKN1A ratioGCST903134037.98e-04
9786Physical activity (Total log acceleration 12am-2am)GCST900614097.97e-04
9787Multiple myelomaGCST906247477.97e-04
9788Docosahexaenoic acid levelsGCST905022427.97e-04
9789Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523FING000003047.95e-04
9790Tea consumptionGCST900969267.93e-04
9791Acute bronchitisFING000000217.92e-04
9792Triglycerides to Total Lipids in Small VLDL percentageGCST904999347.92e-04
9793VSIG2 levelsGCST904710517.91e-04
9794CD58/LTBR ratioGCST903138517.90e-04
9795wg rh intensity-contrast banksstsGCST900038287.89e-04
9796Gout, unspecifiedFING000005897.89e-04
9797Visceral adipose tissue volumeGCST900166717.88e-04
9798Cholesterol to total lipids in IDL percentage (UKB data field 23610)GCST902697077.88e-04
9799Free Cholesterol to Total Lipids in Very Large HDL percentageGCST905003987.87e-04
9800CDKN2D/TACC3 ratioGCST903139927.85e-04
9801Cholesteryl Esters to Total Lipids in Very Large VLDL percentageGCST905005657.84e-04
9802Seropositive rheumatoid arthritis, wideFING000012987.84e-04
9803Otitis media (PheCode 381.1)GCST904759037.83e-04
9804Use of sun/uv protection | Sun exposureUKBB000008877.81e-04
9805CCDC50 levelsGCST904685617.79e-04
9806Free cholesterol in large LDLGCST904979817.78e-04
9807SUSD5 levelsGCST904707897.76e-04
9808Principal component-derived dietary pattern 18GCST901330237.75e-04
9809ACE2/MME ratioGCST903131547.74e-04
9810SNRPB2 levelsGCST904706977.73e-04
9811Phospholipids to total lipids in IDL percentage (UKB data field 23609)GCST902697067.70e-04
9812Sphingomyelin levelsGCST900929827.69e-04
9813Time to complete round | Pairs matchingUKBB000008227.68e-04
9814CRACR2A/IRAG2 ratioGCST903142277.65e-04
9815SPOCK2 levelsGCST902429877.65e-04
9816lymphocyte (absolute count, maximum, inv-norm transformed)GCST904754237.64e-04
9817Total phospholipid levels in lipoprotein particlesGCST905001107.63e-04
9818F-savoury food liking (derived food-liking factor)GCST900948337.62e-04
9819RNASEH2A levelsGCST904704807.60e-04
9820BCAM/CLEC14A ratioGCST903134707.60e-04
9821Ratio of triglycerides to phosphoglyceridesGCST900929837.60e-04
9822SIAE levelsGCST904706297.57e-04
9823ALCAM levelsGCST904682797.55e-04
9824Other disorders of skin and subcutaneous tissueFING000010357.54e-04
9825IDP dMRI TBSS L1 Body of corpus callosumGCST900040787.50e-04
9826Squamous cell carcinoma (MTAG)GCST901374127.49e-04
9827TNFSF13B levelsGCST904709207.47e-04
9828IL18R1 levelsGCST904695657.47e-04
9829FAM3D levelsGCST904691887.46e-04
9830Phosphoglycerides levelsGCST900929387.45e-04
9831Phospholipids in large VLDLGCST904982477.44e-04
9832IDO1 levelsGCST902414907.43e-04
9833Cancer of bronchus; lung (PheCode 165.1)GCST904755737.43e-04
9834Cholesteryl Esters to Total Lipids in Large LDL percentageGCST904979697.42e-04
9835CD164 levelsGCST904686027.42e-04
9836GLOD4/S100A4 ratioGCST903149447.40e-04
9837Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025717.40e-04
9838Free Cholesterol to Total Lipids in Very Large HDL percentageGCST905003977.38e-04
9839CNPY4/MESD ratioGCST903141527.38e-04
9840RTN4IP1 levelsGCST904705077.37e-04
9841Principal component-derived dietary pattern 17GCST901330227.35e-04
9842Mosaic chromosomal alteration of the Y chromosomeGCST901652897.31e-04
9843Physical activity (confirmatory factor analysis Factor 23)GCST903093577.30e-04
9844Depression medicationsFING000003997.30e-04
9845DIABLO/DOK2 ratioGCST903144647.29e-04
9846Free cholesterol in small HDLGCST904994117.28e-04
9847HGF levelsGCST904694497.28e-04
9848Friendships satisfaction | Mental healthUKBB000002737.25e-04
9849Total lipids in VLDL (UKB data field 23424)GCST902695217.24e-04
9850Happiness | Mental healthUKBB000003057.23e-04
9851Prescriptions - alpha1-antagonist|alpha blockerUKBB000006597.21e-04
9852Cholesterol esters in very small VLDLGCST905007497.21e-04
9853Malignant neoplasm of bronchus and lung | Malignant neoplasms of respiratory and intrathoracic organsUKBB000004257.20e-04
9854FUT8 levelsGCST904692817.20e-04
9855Cholesterol to Total Lipids in IDL percentageGCST904975117.19e-04
9856Monocyte percentage (UKB data field 30190)GCST904680917.18e-04
9857Phospholipids in very large HDL (UKB data field 23553)GCST902696507.17e-04
9858IGFBPL1 levelsGCST901793237.14e-04
9859CCN2 levelsGCST904685887.13e-04
9860CDNF levelsGCST904686867.13e-04
9861EPPK1 levelsGCST904691377.12e-04
9862Cod likingGCST900947367.11e-04
9863Illnesses of father - Lung cancer | Family historyUKBB000003447.11e-04
9864N-acetyltaurine levelsGCST901999677.09e-04
9865RLN2 levelsGCST904704747.07e-04
9866Nontoxic multinodular goitreFING000008887.05e-04
9867Platelet countGCST900024027.04e-04
9868Metabolic disordersFING000008167.04e-04
9869PLA2G4A/SPINT2 ratioGCST903156717.02e-04
9870Omega-6 fatty acid levelsGCST905025197.01e-04
9871Cholesterol levels in very small VLDLGCST905007126.98e-04
9872FCRL5/LY96 ratioGCST903148036.97e-04
9873CRACR2A/DNMBP ratioGCST903142266.96e-04
9874Continuous positive airway pressureFING000003496.96e-04
9875ERBB3/IL1R2 ratioGCST903146896.96e-04
9876Alcohol use disorder, Swedish definitionFING000000536.95e-04
9877CXCL10 levelsGCST902747806.93e-04
9878CD72 levelsGCST904686466.92e-04
9879Guilty feelings | Mental healthUKBB000002916.91e-04
9880LTBP3 levelsGCST904698156.86e-04
9881MAP4K5/STAMBP ratioGCST903153826.84e-04
9882MITD1/RHOC ratioGCST903154536.84e-04
9883DNA methylation Hannum age accelerationGCST900142896.81e-04
9884Serum copper levelsGCST901005246.81e-04
9885Total lipids in very large HDL (UKB data field 23552)GCST902696496.79e-04
9886Diacylglycerol_34:3_[M+H-H2O]1+ levelsGCST900601776.79e-04
9887HMBS/PSMG3 ratioGCST903150646.77e-04
9888Total lipids in small VLDLGCST904998496.77e-04
9889ANXA3/ANXA4 ratioGCST903132786.75e-04
9890CDH5/LGALS4 ratioGCST903139566.75e-04
9891Phosphatidylcholine-2O_32:0_[M+H]1+ levelsGCST900602446.74e-04
9892Phospholipids in large HDLGCST904978476.73e-04
9893REST UKBBICA NODEamps25 0009GCST903854926.73e-04
9894Financial situation satisfaction | Mental healthUKBB000002496.72e-04
9895Other disorders of patellaFING000010326.71e-04
9896Spread type - Butter/spreadable butter | DietUKBB000007936.70e-04
9897Cholesterol to total lipids in small VLDL percentage (UKB data field 23600)GCST902696976.69e-04
9898DNMBP/TBC1D5 ratioGCST903145196.69e-04
9899Nummular dermatitisFING000008936.69e-04
9900Usual side of head for mobile phone use - Equally left and right | Electronic device useUKBB000008886.67e-04
9901TNFRSF13B/TNFRSF13C ratioGCST903159316.66e-04
9902Mean diameter of VLDL particlesGCST901327346.66e-04
9903CDH3/TNFRSF21 ratioGCST903139536.66e-04
9904KLK15 levelsGCST904697016.64e-04
9905Free Cholesterol to Total Lipids in Large LDL percentageGCST904980006.63e-04
9906Cholesteryl Esters in Large LDLGCST904979556.62e-04
9907Completion of the aide-memoireGCST900127936.62e-04
9908Primary biliary cholangitis (PBC)FING000012116.61e-04
9909BTN2A1/IFNGR1 ratioGCST903135436.60e-04
9910Platelet countGCST0046036.59e-04
9911WARS levelsGCST904710666.59e-04
9912CD244/TREML2 ratioGCST903137676.59e-04
9913Saturated fatty acids to total fatty acids percentageGCST905021996.58e-04
9914ENTPD2 levelsGCST904691206.57e-04
9915Total concentration of lipoprotein particlesGCST900929906.57e-04
9916Triglycerides to total lipids in IDL percentage (UKB data field 23613)GCST902697106.56e-04
9917IDP dMRI ProbtrackX OD slf rGCST900044726.53e-04
9918PCDH12 levelsGCST904701686.49e-04
9919Phospholipid levels in IDLGCST900928396.49e-04
99205alpha-pregnan-3beta,20alpha-diol monosulfate (2) levelsGCST901998546.46e-04
9921BCL2L11/VASH1 ratioGCST903134856.46e-04
9922UPB1 levelsGCST904710136.44e-04
9923Concentration of HDL particlesGCST904974066.43e-04
9924HSIL lesion of the cervix uteri, vagina or vulvaFING000006256.43e-04
9925MDK levelsGCST904698776.42e-04
9926Kiwi likingGCST900947886.41e-04
9927Triglycerides to Total Lipids in Very Large HDL percentageGCST905005086.41e-04
9928Depressive episode | Mood [affective] disordersUKBB000001666.39e-04
99292s,3R-dihydroxybutyrate levelsGCST901998826.38e-04
9930Cholesterol esters in very large HDLGCST905003446.36e-04
9931HLAE/IL15 ratioGCST903150616.36e-04
9932CD69/SCARF1 ratioGCST903138856.36e-04
9933Types of physical activity in last 4 weeks - Strenuous sports | Physical activityUKBB000008746.34e-04
9934Free Cholesterol to Total Lipids in Large LDL percentageGCST904980076.34e-04
9935BCL2L11/RAB6A ratioGCST903134846.32e-04
9936Total concentration of branched-chain amino acids (leucine + isoleucine + valine)GCST900929846.32e-04
9937Triglycerides in very large HDLGCST905004816.31e-04
9938CRIM1 levelsGCST904688636.29e-04
9939Body mass index (BMI) | Impedance measuresUKBB000001046.28e-04
9940Saturated fatty acids levelsGCST905021946.27e-04
9941Docosahexaenoic acid levelsGCST905019786.26e-04
9942Cancer code, self-reported: prostate cancer (UKB data field 20001_1044)GCST900419056.26e-04
9943T1 FreeSurfer DK lh MeanThickness thicknessGCST903856566.25e-04
9944Urine dimethylglycine levels in chronic kidney diseaseGCST902650456.25e-04
9945CD28 levelsGCST904686166.24e-04
9946HippSubfield rh volume subiculum-headGCST900026936.22e-04
9947Type 1 diabetes (PheCode 250.1)GCST904756616.21e-04
9948MME levelsGCST904699146.20e-04
9949Alcohol usually taken with meals | AlcoholUKBB000000256.19e-04
9950Cholesteryl esters to total lipids in IDL percentage (UKB data field 23611)GCST902697086.19e-04
9951Phospholipids in small VLDL (UKB data field 23511)GCST902696086.19e-04
9952Principal component-derived dietary pattern 20GCST901330256.19e-04
9953LDLR/MEGF9 ratioGCST903153106.17e-04
9954DNAJB1/SIRT2 ratioGCST903145116.17e-04
9955APOB levelsGCST904971306.16e-04
9956Acute alcohol intoxicationFING000000146.16e-04
9957DTI TBSS FA External capsule LGCST903844136.15e-04
9958Diseases of male genital organsFING000004266.15e-04
9959Phospholipids in very large HDLGCST905004516.14e-04
9960CD300C/HAVCR2 ratioGCST903137896.12e-04
9961IL1B levelsGCST904695706.10e-04
9962LGALS4/TIE1 ratioGCST903153166.10e-04
9963Liver enzyme levels (alkaline phosphatase)GCST900134066.09e-04
9964Triglyceride levels in chylomicrons and extremely large VLDLGCST905010686.08e-04
9965Phospholipid levels in medium LDLGCST900929126.07e-04
9966Total cholesterol levelsGCST900187546.07e-04
9967Cholesteryl ester levels in small VLDLGCST900929706.06e-04
9968KLK6/PTPRN2 ratioGCST903152566.06e-04
9969C9 Carnitine levels in chronic kidney diseaseGCST902576826.05e-04
9970Mean platelet volume during first trimester of pregnancyGCST903022296.04e-04
9971BA-exvivo lh area BA4pGCST900032126.03e-04
9972Phospholipids to Total Lipids in Small VLDL percentageGCST904998956.03e-04
9973CDH1/CDH17 ratioGCST903139456.01e-04
9974SIT1 levelsGCST904706446.01e-04
9975HSIL lesion of the cervix uteriFING000006246.01e-04
9976Blood cell traits latent factor 2 (red cell)GCST905592446.00e-04
9977Chromatiales abundance in stoolGCST900323186.00e-04
9978CDSN/NECTIN4 ratioGCST903139985.98e-04
9979Phospholipid levels in large LDLGCST901326485.98e-04
9980Triglycerides in large HDLGCST904978885.97e-04
9981STX8/USP8 ratioGCST903158965.96e-04
9982CCL3 levelsGCST904685825.94e-04
9983Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025665.94e-04
9984CEACAM1 levelsGCST904686925.93e-04
9985CLPS/PLA2G1B ratioGCST903141405.93e-04
9986Syncope and collapse | symptomsUKBB000008015.92e-04
9987TDP1 levelsGCST904708265.91e-04
9988CCL28 levelsGCST904685805.91e-04
9989T1 CAT volume L CingulateGyrusanteriordivisionGCST903840565.90e-04
9990Statin medicationFING000013315.86e-04
9991MANF/NCK2 ratioGCST903153595.86e-04
9992NUDT5/SERPINB1 ratioGCST903155815.86e-04
9993CD163/MARCO ratioGCST903137375.84e-04
9994Concentration of medium HDL particlesGCST904986175.84e-04
9995CDSN levelsGCST904686885.84e-04
9996IL6ST/MARCO ratioGCST903151675.83e-04
9997Triglycerides in medium VLDL (UKB data field 23508)GCST902696055.82e-04
9998COVID-19 vaccinationGCST902556135.81e-04
9999Incidence of bisecting GlcNAc in all fucosylated disialylated structures (GP57)GCST906687355.79e-04
10000Concentration of small VLDL particles (UKB data field 23509)GCST902696065.78e-04